Making memory at birth: Understanding the differentiation of natural killer T cells

Current Opinion in Immunology

Volumn 24, Issue 2, 2012, Pages 184-190

  Engel, Isaac ^a   Kronenberg, Mitchell ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD150 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN PLZF; RAS PROTEIN; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANTIGEN DETECTION; CELL MATURATION; CELL SELECTION; HUMAN; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MEMORY T LYMPHOCYTE; NATURAL KILLER T CELL; NONHUMAN; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; THYMOCYTE; TISSUE DISTRIBUTION;

ANIMALS; CELL DIFFERENTIATION; HUMANS; IMMUNOLOGIC MEMORY; MAP KINASE SIGNALING SYSTEM; NATURAL KILLER T-CELLS; THYMUS GLAND;

EID: 84859158571     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2012.01.012     Document Type: Review

References (57)

1. Bendelac A., Savage P.B., Teyton L. The biology of NKT cells. Annu Rev Immunol 2007, 25:297-336.
2. Le Bourhis L., Guerri L., Dusseaux M., Martin E., Soudais C., Lantz O. Mucosal-associated invariant T cells: unconventional development and function. Trends Immunol 2011, 32:212-218.
3. Brossay L., Chioda M., Burdin N., Koezuka Y., Casorati G., Dellabona P., Kronenberg M. Cd1d-mediated recognition of an alpha-galactosylceramide by natural killer t cells is highly conserved through mammalian evolution. J Exp Med 1998, 188:1521-1528.
4. Uldrich A.P., Patel O., Cameron G., Pellicci D.G., Day E.B., Sullivan L.C., Kyparissoudis K., Kjer-Nielsen L., Vivian J.P., Cao B., et al. A semi-invariant Valpha10+ t cell antigen receptor defines a population of natural killer T cells with distinct glycolipid antigen-recognition properties. Nat Immunol 2011, 12:616-623.
5. Brigl M., van den Elzen P., Chen X., Meyers J.H., Wu D., Wong C.H., Reddington F., Illarianov P.A., Besra G.S., Brenner M.B., Gumperz J.E. Conserved and heterogeneous lipid antigen specificities of Cd1d-restricted NKT cell receptors. J Immunol 2006, 176:3625-3634.
6. Das R., Sant'Angelo D.B., Nichols K.E. Transcriptional control of invariant NKT cell development. Immunol Rev 2010, 238:195-215.
7. Shimamura M., Ohteki T., Beutner U., MacDonald H.R. Lack of directed V alpha 14-J alpha 281 rearrangements in NK1+ T cells. Eur J Immunol 1997, 27:1576-1579.
8. Benlagha K., Wei D.G., Veiga J., Teyton L., Bendelac A. Characterization of the early stages of thymic NKT cell development. J Exp Med 2005, 202:485-492.
9. Bezbradica J.S., Hill T., Stanic A.K., Van Kaer L., Joyce S. Commitment toward the natural T (iNKT) cell lineage occurs at the CD4+8+ stage of thymic ontogeny. Proc Natl Acad Sci USA 2005, 102:5114-5119.
10. Egawa T., Eberl G., Taniuchi I., Benlagha K., Geissmann F., Hennighausen L., Bendelac A., Littman D.R. Genetic evidence supporting selection of the Valpha14i NKT cell lineage from double-positive thymocyte precursors. Immunity 2005, 22:705-716.
11. D'Cruz L.M., Knell J., Fujimoto J.K., Goldrath A.W. An essential role for the transcription factor HEB in thymocyte survival TCRa rearrangement and the development of natural killer T cells. Nat Immunol 2010, 11:240-249.
12. Zhou D., Mattner J., Cantu C., Schrantz N., Yin N., Gao Y., Sagiv Y., Hudspeth K., Wu Y.P., Yamashita T., et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 2004, 306:1786-1789.
13. Porubsky S., Speak A.O., Luckow B., Cerundolo V., Platt F.M., Grone H.J. Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (igb3) deficiency. Proc Natl Acad Sci USA 2007, 104:5977-5982.
14. Brennan P.J., Tatituri R.V., Brigl M., Kim E.Y., Tuli A., Sanderson J.P., Gadola S.D., Hsu F.F., Besra G.S., Brenner M.B. Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals. Nat Immunol 2011, 12:1202-1211.
15. Stanic A.K., De Silva A.D., Park J.J., Sriram V., Ichikawa S., Hirabyashi Y., Hayakawa K., Van Kaer L., Brutkiewicz R.R., Joyce S. Defective presentation of the CD1d1-restricted natural Va14Ja18 nkt lymphocyte antigen caused by beta-d-glucosylceramide synthase deficiency. Proc Natl Acad Sci USA 2003, 100:1849-1854.
16. Mallevaey T., Clarke A.J., Scott-Browne J.P., Young M.H., Roisman L.C., Pellicci D.G., Patel O., Vivian J.P., Matsuda J.L., McCluskey J., et al. A molecular basis for NKT cell recognition of CD1d-self-antigen. Immunity 2011, 34:315-326.
17. Wei D.G., Lee H., Park S.-H., Beaudoin L., Teyton L., Lehuen A., Bendelac A. Expansion and long-range differentiation of the NKT cell lineage in mice expressing CD1d exclusively on cortical thymocytes. J Exp Med 2005, 202:239-248.
18. Griewank K., Borowski C., Rietdijk S., Wang N., Julien A., Wei D.G., Mamchak A.A., Terhorst C., Bendelac A. Homotypic interactions mediated by slamf1 and slamf6 receptors control NKT cell lineage development. Immunity 2007, 27:751-762.
19. Kronenberg M., Engel I. On the road: progress in finding the unique pathway of invariant NKT cell differentiation. Curr Opin Immunol 2007, 19:186-193.
20. Nunez-Cruz S., Yeo W.C., Rothman J., Ojha P., Bassiri H., Juntilla M., Davidson D., Veillette A., Koretzky G.A., Nichols K.E. Differential requirement for the sap-fyn interaction during NK T cell development and function. J Immunol 2008, 181:2311-2320.
21. Alberola-Ila J., Hogquist K.A., Swan K.A., Bevan M.J., Perlmutter R.M. Positive and negative selection invoke distinct signaling pathways. J Exp Med 1996, 184:9-18.
22. Hu T., Gimferrer I., Simmons A., Wiest D., Alberola-Ila J. The ras/mapk pathway is required for generation of iNKT cells. PLoS ONE 2011, 6:e19890.
23. Lazarevic V., Zullo A.J., Schweitzer M.N., Staton T.L., Gallo E.M., Crabtree G.R., Glimcher L.H. The gene encoding early growth response 2, a target of the transcription factor NFAT, is required for the development and maturation of natural killer T cells. Nat Immunol 2009, 10:306-313.
24. Seiler MP, Mathew R, Liszewski MK, Spooner C, Barr K, Meng F, Singh H, Bendelac A: Elevated and sustained Egr1 and Egr2 expression controls NKT lineage differentiation in response to TCR signaling. Nat Immunol 2012, in press.
25. Shen S., Chen Y., Gorentla B.K., Lu J., Stone J.C., Zhong X.P. Critical roles of rasgrp1 for invariant NKT cell development. J Immunol 2011, 187:4467-4473.
26. Chun T., Page M.J., Gapin L., Matsuda J.L., Xu H., Nguyen H., Kang H.S., Stanic A.K., Joyce S., Koltun W.A., et al. CD1d-expressing dendritic cells but not thymic epithelial cells can mediate negative selection of NKT cells. J Exp Med 2003, 197:907-918.
27. Shen S., Wu J., Srivatsan S., Gorentla B.K., Shin J., Xu L., Zhong X.P. Tight regulation of diacylglycerol-mediated signaling is critical for proper invariant NKT cell development. J Immunol 2011, 187:2122-2129.
28. Baldanzi G., Pighini A., Bettio V., Rainero E., Traini S., Chianale F., Porporato P.E., Filigheddu N., Mesturini R., Song S., et al. SAP-mediated inhibition of diacylglycerol kinase alpha regulates TCR-induced diacylglycerol signaling. J Immunol 2011, 187:5941-5951.
29. Lee A.J., Zhou X., Chang M., Hunzeker J., Bonneau R.H., Zhou D., Sun S.C. Regulation of natural killer T-cell development by deubiquitinase CYLD. EMBO J 2010, 29:1600-1612.
30. Yu S., Cantorna M.T. The Vitamin D receptor is required for iNKT cell development. Proc Natl Acad Sci USA 2008, 105:5207-5212.
31. Kennedy M.K., Glaccum M., Brown S.N., Butz E.A., Viney J.L., Embers M., Matsuki N., Charrier K., Sedger L., Willis C.R., et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med 2000, 191:771-780.
32. Matsuda J.L., Gapin L., Sidobre S., Kieper W.C., Tan J.T., Ceredig R., Surh C.D., Kronenberg M. Homeostasis of V alpha 14i NKT cells. Nat Immunol 2002, 3:966-974.
33. Gordy L.E., Bezbradica J.S., Flyak A.I., Spencer C.T., Dunkle A., Sun J., Stanic A.K., Boothby M.R., He Y.W., Zhao Z., et al. Il-15 regulates homeostasis and terminal maturation of NKT cells. J Immunol 2011, 187:6335-6345.
34. Yue X., Izcue A., Borggrefe T. Essential role of mediator subunit med1 in invariant natural killer T-cell development. Proc Natl Acad Sci USA 2011, 108:17105-17110.
35. Yu S., Cantorna M.T. Epigenetic reduction in invariant nkt cells following in utero Vitamin D deficiency in mice. J Immunol 2011, 186:1384-1390.
36. Milpied P., Massot B., Renand A., Diem S., Herbelin A., Leite-de-Moraes M., Rubio M.T., Hermine O. Il-17-producing invariant NKT cells in lymphoid organs are recent thymic emigrants identified by neuropilin-1 expression. Blood 2011, 118:2993-3002.
37. Kovalovsky D., Uche O.U., Eladad S., Hobbs R.M., Yi W., Alonzo E., Chua K., Eidson M., Kim H.J., Im J.S., et al. The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat Immunol 2008, 9:1055-1064.
38. Savage A.K., Constantinides M.G., Han J., Picard D., Martin E., Li B., Lantz O., Bendelac A. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 2008, 29:391-403.
39. Constantinides M.G., Picard D., Savage A.K., Bendelac A. A naive-like population of human CD1d-restricted T cells expressing intermediate levels of promyelocytic leukemia zinc finger. J Immunol 2011, 187:309-315.
40. Kovalovsky D., Alonzo E.S., Uche O.U., Eidson M., Nichols K.E., Sant'Angelo D.B. PLZF induces the spontaneous acquisition of memory/effector functions in t cells independently of NKT cell-related signals. J Immunol 2010, 184:6746-6755.
41. Savage A.K., Constantinides M.G., Bendelac A. Promyelocytic leukemia zinc finger turns on the effector T cell program without requirement for agonist TCR signaling. J Immunol 2011, 186:5801-5806.
42. Thomas S.Y., Scanlon S.T., Griewank K.G., Constantinides M.G., Savage A.K., Barr K.A., Meng F., Luster A.D., Bendelac A. PLZF induces an intravascular surveillance program mediated by long-lived LFA-1-ICAM-1 interactions. J Exp Med 2011, 208:1179-1188.
43. Bendelac A., Killeen N., Littman D.R., Schwartz R.H. A subset of CD4+ thymocytes selected by MHCclass I molecules. Science 1994, 263:1774-1778.
44. Engel I., Hammond K., Sullivan B.A., He X., Taniuchi I., Kappes D., Kronenberg M. Co-receptor choice by V alpha14i NKT cells is driven by TH-POK expression rather than avoidance of CD8-mediated negative selection. J Exp Med 2010, 207:1015-1029.
45. He X., He X., Dave V.P., Zhang Y., Hua X., Nicolas E., Xu W., Roe B.A., Kappes D.J. The zinc finger transcription factor TH-POK regulates CD4 versus CD8 T-cell lineage commitment. Nature 2005, 433:826-833.
46. Sun G., Liu X., Mercado P., Jenkinson S.R., Kypriotou M., Feigenbaum L., Galera P., Bosselut R. The zinc finger protein ckrox directs CD4 lineage differentiation during intrathymic T cell positive selection. Nat Immunol 2005, 6:373-381.
47. Wang L., Carr T., Xiong Y., Wildt K.F., Zhu J., Feigenbaum L., Bendelac A., Bosselut R. The sequential activity of GATA3 and THPOK is required for the differentiation of CD1d-restricted CD4+ NKT cells. Eur J Immunol 2010, 40:2385-2390.
48. Hu T., Simmons A., Yuan J., Bender T.P., Alberola-Ila J. The transcription factor c-myb primes CD4+CD8+ immature thymocytes for selection into the iNKT lineage. Nat Immunol 2010, 11:435-441.
49. Bezman N.A., Chakraborty T., Bender T., Lanier L.L. Mir-150 regulates the development of NK and iNKT cells. J Exp Med 2011, 208:2717-2731.
50. Albu D.I., VanValkenburgh J., Morin N., Califano D., Jenkins N.A., Copeland N.G., Liu P., Avram D. Transcription factor Bcl11b controls selection of invariant natural killer T-cells by regulating glycolipid presentation in double-positive thymocytes. Proc Natl Acad Sci USA 2011, 108:6211-6216.
51. Albu D.I., Feng D., Bhattacharya D., Jenkins N.A., Copeland N.G., Liu P., Avram D. Bcl11b is required for positive selection and survival of double-positive thymocytes. J Exp Med 2007, 204:3003-3015.
52. Godfrey D.I., Stankovic S., Baxter A.G. Raising the NKT cell family. Nat Immunol 2010, 11:197-206.
53. Doisne J.M., Becourt C., Amniai L., Duarte N., Le Luduec J.B., Eberl G., Benlagha K. Skin and peripheral lymph node invariant NKT cells are mainly retinoic acid receptor-related orphan receptor (gamma)t+ and respond preferentially under inflammatory conditions. J Immunol 2009, 183:2142-2149.
54. Monteiro M., Almeida C.F., Caridade M., Ribot J.C., Duarte J., Agua-Doce A., Wollenberg I., Silva-Santos B., Graca L. Identification of regulatory Foxp3+ invariant NKT cells induced by TGF-beta. J Immunol 2010, 185:2157-2163.
55. Chang P.P., Barral P., Fitch J., Pratama A., Ma C.S., Kallies A., Hogan J.J., Cerundolo V., Tangye S.G., Bittman R., et al. Identification of Bcl-6-dependent follicular helper NKT cells that provide cognate help for B cell responses. Nat Immunol 2011, 13:35-43.
56. King I.L., Fortier A., Tighe M., Dibble J., Watts G.F., Veerapen N., Haberman A.M., Besra G.S., Mohrs M., Brenner M.B., et al. Invariant natural killer T cells direct B cell responses to cognate lipid antigen in an IL-21-dependent manner. Nat Immunol 2011, 13:44-50.
57. Moreira-Texeira L., Resende M., Devergne O., Herbeuval J.-P., Hermine O., Schneider E., Dy M., Cordeiro-da-Silva A., Leite-de-Moraes M.C. Rapamycin combined with TGF-β converts human invariant NKT cells into suppressive FoxP3+ regulatory cells. J Immunol 2012, 188:624-631.